Top compounds associated with response to CLDN5


Feature Type Standardized
Nominal ANOVA
mRNA Cyclopamine GDSC1000 pan-cancer AAC 0.18 0.0005
mRNA pluripotin CTRPv2 pan-cancer AAC -0.11 0.0009
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.11 0.0009
mRNA RG-108 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.11 0.001
mRNA SZ4TA2 CTRPv2 pan-cancer AAC 0.17 0.001
mRNA A-804598 CTRPv2 pan-cancer AAC 0.14 0.001
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
Download CSV